AZITHROMYCIN AND CO-AMOXICLAV AT DIFFERENT DOSAGES HAVE BEEN PROMOTED FOR TREATING CHILDREN WITH LOWER RESPIRATORY TRACT INFECTIONS. CDF 2026, 53 (02), 5041-5046. https://doi.org/10.48047/dhpsth87.